Christopher A Johnson (C Andrew Johnson, Andrew C Johnson)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Glycemic Control

Extracellular Matrix

Epithelial Mesenchymal Transition

Top Venues

Science advances

Science translational medicine

Cancer immunology research

Vanderbilt University Department of Cancer Biology

University of Virginia (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vanderbilt University Department of Cancer Biology Jul 10 2014

United States

Research Assistant II

Education History

University of Virginia Aug 25 2009 - May 22 2013

United States

BSC

Publications

Wenjun Wang, Lauren A Hapach, Lauren A Griggs, Kyra Smart, Yusheng Wu, Paul V Taufalele, Matthew M Rowe, Katherine M Young, Madison E Bates, Christopher A Johnson, Nicholas J Ferrell, Ambra Pozzi, Cynthia A Reinhart-King
Diabetic hyperglycemia promotes primary tumor progression through glycation-induced tumor extracellular matrix stiffening. Science advances 8 (46) (2022)
Jinming Yang, Chi Yan, Anna E Vilgelm, Sheau-Chiann Chen, Gregory D Ayers, Christopher A Johnson, Ann Richmond
Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity. Cancer immunology research 9 (2) (2020)
Anna E Vilgelm, Nabil Saleh, Rebecca L Shattuck-Brandt, Kelsie Riemenschneider, Lauren Slesur, Sheau-Chiann Chen, Christopher A Johnson, Jinming Yang, Ashlyn N Blevins, Chi Yan, Douglas B Johnson, Rami Nayef Al-Rohil, Ensar Halilovic, Rondi M Kauffmann, Mark Kelley, Gregory D Ayers, Ann Richmond
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21. Science translational medicine 11 (505) (2020)